Expression of GCDFP‐15 and AR decreases in larger or node‐positive apocrine carcinomas of the breast
- 25 July 2005
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 47 (2) , 195-201
Abstract
Aims : Apocrine carcinoma of the breast is typically, though not always, positive for gross cystic disease fluid protein‐15 (GCDFP‐15). In order to clarify the clinical significance of GCDFP‐15 in apocrine carcinomas, GCDFP‐15 expression was examined in apocrine carcinomas of different stages and compared with clinicopathological factors. Apocrine lesions reportedly exhibit an unusual immunohistochemical status, expressing androgen receptors (AR) instead of oestrogen receptors (ER), progesterone receptors (PR), or bcl‐2. Their expression was also examined.Methods and results : Fifty‐two apocrine carcinomas were examined immunohistochemically. Thirty‐nine (75%) and 29 (56%) were positive for GCDFP‐15 and AR, respectively. GCDFP‐15 positivity was significantly lower in infiltrating carcinomas than intraductal carcinomas (P = 0.0111). In infiltrating carcinomas, GCDFP‐15 positivity was significantly low in tumours ≥ 15 mm (P = 0.0005) and node‐positive tumours (P = 0.0004). Similar phenomena were observed for AR. Rare cases were positive for ER (3.8%), PR (5.8%), and bcl‐2 (1.9%).Conclusions : GCDFP‐15 positivity is transient and should not be considered a definitive marker of apocrine carcinomas. Cases which have apocrine features but lack GCDFP‐15 expression should rather be considered as advanced apocrine carcinomas. ER/PR/bcl‐2 negativity will sometimes be helpful to confirm the diagnosis of apocrine carcinoma, because it is more consistent than GCDFP‐15/AR positivity.Keywords
This publication has 19 references indexed in Scilit:
- Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breastVirchows Archiv, 2002
- Apocrine ductal carcinoma in situ of the breast: Histologic classification and expression of biologic markersHuman Pathology, 2001
- Immunohistochemical Analysis of Apocrine Breast LesionsPathology - Research and Practice, 1997
- Androgen Receptor Expression Along with Loss of bcl-2, ER, and PR Expression in Benign and Malignant Apocrine Lesions of the Breast: Implications for TherapyThe Breast Journal, 1996
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture — modulation by steroid hormonesBreast Cancer Research and Treatment, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Invasive apocrine carcinoma of the breast: A long term follow-up study of 34 casesBreast Cancer Research and Treatment, 1988
- Breast gross cystic disease protein 15 in human breast cancer in cultureEuropean Journal of Cancer and Clinical Oncology, 1988
- Androgen metabolism and apocrine differentiation in human breast cancerBreast Cancer Research and Treatment, 1985